{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:53:00Z","timestamp":1782978780082,"version":"3.54.5"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T00:00:00Z","timestamp":1546819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"AGING PROJECT ? Department of Excellence ? Universit? del Piemonte Orientale","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s11481-018-09831-0","type":"journal-article","created":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T21:23:24Z","timestamp":1546896204000},"page":"74-81","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Beta2-Adrenoceptor Agonists in Parkinson\u2019s Disease and Other Synucleinopathies"],"prefix":"10.1007","volume":"15","author":[{"given":"Luca","family":"Magistrelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6862-9468","authenticated-orcid":false,"given":"Cristoforo","family":"Comi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,7]]},"reference":[{"key":"9831_CR1","doi-asserted-by":"publisher","unstructured":"A\u011fa\u00e7 D, Estrada LD, Maples R, Hooper LV , Farrar JD. (2018). The \u03b22-adrenergic receptor controls inflammation by driving rapid IL-10 secretion Brain Behav Immun. \nhttps:\/\/doi.org\/10.1016\/j.bbi.2018.09.004","DOI":"10.1016\/j.bbi.2018.09.004"},{"key":"9831_CR2","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/srep00953","volume":"2","author":"T Alberio","year":"2012","unstructured":"Alberio T, Pippione AC, Zibetti M, Olgiati S, Cecconi D, Comi C, Lopiano L, Fasano M (2012a) Discovery and verification of panels of T-lymphocyte proteins as biomarkers of Parkinson's disease. Sci Rep 2:953","journal-title":"Sci Rep"},{"key":"9831_CR3","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/iub.1073","volume":"64","author":"T Alberio","year":"2012","unstructured":"Alberio T, Pippione AC, Comi C, Olgiati S, Cecconi D, Zibetti M, Lopiano L, Fasano M (2012b) Dopaminergic therapies modulate the T-CELL proteome of patients with Parkinson's disease. IUBMB Life 64:846\u2013852","journal-title":"IUBMB Life"},{"key":"9831_CR4","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1212\/WNL.44.8.1511","volume":"44","author":"GM Alexander","year":"1994","unstructured":"Alexander GM, Schwartzman RJ, Nukes TA, Grothusen JR, Hooker MD (1994) \u03b22-adrenergic agonist as adjunct therapy to levodopa in Parkinson\u2019s disease. Neurology 44:1511\u20131513","journal-title":"Neurology"},{"key":"9831_CR5","doi-asserted-by":"crossref","unstructured":"Arango V, Ernsberger P, Reis DJ, Mann JJ (1990) Demonstration of high- and low-affinity beta-adrenergic receptors in slide-mounted sections of rat and human brain. Brain Res 516:113\u2013121","DOI":"10.1016\/0006-8993(90)90904-P"},{"key":"9831_CR6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/nan.12303","volume":"42","author":"RA Barker","year":"2016","unstructured":"Barker RA, Williams-Gray CH (2016) Review: the spectrum of clinical features seen with alpha synuclein pathology. Neuropathol Appl Neurobiol 42:6\u201319","journal-title":"Neuropathol Appl Neurobiol"},{"key":"9831_CR7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","volume":"20","author":"H Bernheimer","year":"1973","unstructured":"Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. J Neurol Sci 20:415\u2013455","journal-title":"J Neurol Sci"},{"key":"9831_CR8","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/jnc.13125","volume":"134","author":"N Bhide","year":"2015","unstructured":"Bhide N, Lindenbach D, Barnum CJ, George JA, Surrena MA, Bishop C (2015) Effects of beta-adrenergic receptor antagonist propranolol on dyskinesia and L-DOPA-induced striatal DA efflux in the hemi-parkinsonian rat. J Neurochem 134:222\u2013232","journal-title":"J Neurochem"},{"key":"9831_CR9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.brainres.2015.04.015","volume":"1614","author":"M Bottner","year":"2015","unstructured":"Bottner M, Fricke T, M\u00fcller M, Barrenschee M, Deuschl G, Schneider SA et al (2015) Alpha-synuclein is associated with the synaptic vesicle apparatus in the human and rat enteric nervous system. Brain Res 1614:51\u201359","journal-title":"Brain Res"},{"key":"9831_CR10","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1042\/BST0351119","volume":"35","author":"CG Brown","year":"2007","unstructured":"Brown CG (2007) Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase. Biochem Soc Trans 35:1119\u20131121","journal-title":"Biochem Soc Trans"},{"key":"9831_CR11","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1371\/journal.pone.0003152","volume":"3","author":"RM Bujis","year":"2008","unstructured":"Bujis RM, van der Vliet J, Garidou ML, Huitinga I, Escobar C (2008) Spleen vagal denervation inhibits the production of antibodies to circulating antigens. PLoS One 3:3152","journal-title":"PLoS One"},{"key":"9831_CR12","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3389\/fnins.2018.00626","volume":"12","author":"LM Butkovich","year":"2018","unstructured":"Butkovich LM, Houser MC, Tansey MG (2018) \u03b1-Synuclein and noradrenergic modulation of immune cells in Parkinson\u2019s disease pathogenesis. Front Neurosci 12:626. \nhttps:\/\/doi.org\/10.3389\/fnins.2018.00626","journal-title":"Front Neurosci"},{"key":"9831_CR13","first-page":"89","volume":"21","author":"G Cappellano","year":"2013","unstructured":"Cappellano G, Carecchio M, Fleetwood T, Magistrelli L, Cantello R, Dianzani U et al (2013) Immunity and inflammation in neurodegenerative diseases. Am J Neurodegener Dis 21:89\u2013107","journal-title":"Am J Neurodegener Dis"},{"key":"9831_CR14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0006-8993(84)90117-3","volume":"322","author":"R Cash","year":"1984","unstructured":"Cash R, Ruberg M, Raisman R, Agid Y (1984) Adrenergic receptors in Parkinson\u2019s disease. Brain Res 322:269\u2013275","journal-title":"Brain Res"},{"key":"9831_CR15","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.parkreldis.2014.10.010","volume":"20","author":"C Comi","year":"2014","unstructured":"Comi C, Magistrelli L, Oggioni GD, Carecchio M, Fleetwood T, Cantello R, Mancini F, Antonini A (2014) Peripheral nervous system involvement in Parkinson\u2019s disease: evidence and controversies. Parkinsonism Relat Disord 20:1329\u20131334","journal-title":"Parkinsonism Relat Disord"},{"key":"9831_CR16","doi-asserted-by":"crossref","first-page":"pii: E242","DOI":"10.3390\/ijms18020242","volume":"24","author":"C Comi","year":"2017","unstructured":"Comi C, Ferrari M, Marino F, Magistrelli L, Cantello R, Riboldazzi G et al (2017) Polymorphisms of dopamine receptor genes and risk of L-Dopa-induced dyskinesia in parkinson's disease. Int J Mol Sci 24:pii: E242","journal-title":"Int J Mol Sci"},{"key":"9831_CR17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fneur.2018.00213","volume":"9","author":"L Corrado","year":"2018","unstructured":"Corrado L, De Marchi F, Tunesi S, Oggioni GD, Carecchio M, Magistrelli L et al (2018) The length of SNCA Rep1 microsatellite may influence cognitive evolution in Parkinson's disease. Front Neurol 9:213","journal-title":"Front Neurol"},{"key":"9831_CR18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11481-012-9410-z","volume":"8","author":"M Cosentino","year":"2013","unstructured":"Cosentino M, Marino F (2013) Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks? J NeuroImmune Pharmacol 8:163\u2013179","journal-title":"J NeuroImmune Pharmacol"},{"key":"9831_CR19","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0024-3205(99)00023-5","volume":"64","author":"M Cosentino","year":"1999","unstructured":"Cosentino M, Marino F, Bombelli R, Ferrari M, Lecchini S, Frigo G (1999) Endogenous catecholamine synthesis, metabolism, storage and uptake in human neutrophils. Life Sci 64:975\u2013981","journal-title":"Life Sci"},{"key":"9831_CR20","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1182\/blood-2006-01-028423","volume":"109","author":"M Cosentino","year":"2007","unstructured":"Cosentino M, Fietta AM, Ferrari M, Rasini E, Bombelli R, Carcano E, Saporiti F, Meloni F, Marino F, Lecchini S (2007) Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine\/paracrine inhibitory functional loop. Blood 109:632\u2013642","journal-title":"Blood"},{"key":"9831_CR21","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.humimm.2015.09.032","volume":"76","author":"M Cosentino","year":"2015","unstructured":"Cosentino M, Ferrari M, Kustrimovic N, Rasini E, Marino F (2015) Influence of dopamine receptor gene polymorphisms on circulating T lymphocytes: a pilot study in healthy subjects. Hum Immunol 76:747\u2013752","journal-title":"Hum Immunol"},{"key":"9831_CR22","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1161\/01.STR.0000125855.17686.6d","volume":"35","author":"C Culmsee","year":"2004","unstructured":"Culmsee C, Junker V, Kremers W, Thal S, Plesnila N, Krieglstein J (2004) Combination therapy in ischemic stroke: synergistic neuroprotective effects of Memantine and Clenbuterol. Stroke 35:1197\u20131202","journal-title":"Stroke"},{"key":"9831_CR23","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF00711542","volume":"12","author":"L Elliott","year":"1992","unstructured":"Elliott L, Brooks W, Roszman T (1992) Inhibition of anti-CD3 monoclonal antibody-induced T-cell proliferation by dexamethasone, isoproterenol, or prostaglandin E2 either alone or in combination. Cell Mol Neurobiol 12:411\u2013427","journal-title":"Cell Mol Neurobiol"},{"key":"9831_CR24","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/ana.25364","volume":"84","author":"AJ Espay","year":"2018","unstructured":"Espay AJ, Morgante F, Merola A, Fasano A, Marsili L, Fox SH, Bezard E, Picconi B, Calabresi P, Lang AE (2018) Levodopa-induced dyskinesia in Parkinson disease: current and evolving concepts. Ann Neurol 84:797\u2013811. \nhttps:\/\/doi.org\/10.1002\/ana.25364","journal-title":"Ann Neurol"},{"key":"9831_CR25","doi-asserted-by":"crossref","first-page":"L675","DOI":"10.1152\/ajplung.2000.279.4.L675","volume":"279","author":"P Farmer","year":"2000","unstructured":"Farmer P, Pugin J (2000) Beta-adrenergic agonists exert their \u201canti-inflammatory\u201d effects in monocytic cells through the IkappaB\/NF-kappaB pathway. Am J Physiol Lung Cell Mol Physiol 279:L675\u2013L682","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"9831_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41531-017-0013-5","volume":"3","author":"HE Gendelman","year":"2017","unstructured":"Gendelman HE, Zhang Y, Santamaria P, Olson KE, Schutt CR, Bhatti D, Shetty BLD, Lu Y, Estes KA, Standaert DG, Heinrichs-Graham E, Larson LA, Meza JL, Follett M, Forsberg E, Siuzdak G, Wilson TW, Peterson C, Mosley RL (2017) Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1clinical Parkinson\u2019s disease. Npj Parkinsons disease 3:10. \nhttps:\/\/doi.org\/10.1038\/s41531-017-0013-5","journal-title":"Npj Parkinsons disease"},{"key":"9831_CR27","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3233\/JPD-150630","volume":"5","author":"S George","year":"2015","unstructured":"George S, Brundin P (2015) Immunotherapy in Parkinson's disease: micromanaging alpha-Synuclein aggregation. J Parkinsons Dis 5:413\u2013424","journal-title":"J Parkinsons Dis"},{"key":"9831_CR28","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P et al (2008) Movement Disorder Society UPDRS revision task force. Movement Disorder Society sponsored revision of the unified Parkinson\u2019s disease rating scale (MDSUPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129","journal-title":"Mov Disord"},{"key":"9831_CR29","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/00002826-199310000-00004","volume":"16","author":"B Gomez-Mancilla","year":"1993","unstructured":"Gomez-Mancilla B, Bedard PJ (1993) Effect of nondopaminergic drugs on L-Dopa-induced dyskinesias in MPTP-treated monkeys. Clin Neuropharmacol 16:418\u2013427","journal-title":"Clin Neuropharmacol"},{"key":"9831_CR30","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/mds.108","volume":"33","author":"N Gronich","year":"2018","unstructured":"Gronich N, Abernethy DR, Auriel E, Lavi I, Rennert G, Saliba W (2018) \u03b22-adrenoceptor agonists and antagonists and risk of Parkinson's disease. Mov Disord 33:1465\u20131471","journal-title":"Mov Disord"},{"key":"9831_CR31","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/0140-6736(92)90313-R","volume":"339","author":"R Hishida","year":"1992","unstructured":"Hishida R, Kurahashi K, Narita S, Baba T, Matsunaga M (1992) \u201cWearing-off\u201d and beta 2-adrenoceptor agonist in Parkinson\u2019s disease. Lancet 339:870","journal-title":"Lancet"},{"key":"9831_CR32","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/cphy.c130051","volume":"4","author":"MJ Kenney","year":"2014","unstructured":"Kenney MJ, Ganta CK (2014) Autonomic nervous system and immune system interactions. Compr Physiol 4:1177\u20131200","journal-title":"Compr Physiol"},{"key":"9831_CR33","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1001\/archneurol.2010.222","volume":"67","author":"SJ Khoury","year":"2010","unstructured":"Khoury SJ, Healy BC, Kivis\u00e4kk P, Viglietta V, Egorova S, Guttmann CR (2010) A randomized controlled double-masked trial of albuterol add-on therapy in patients with multiple sclerosis. Arch Neurol 67:1055\u20131061","journal-title":"Arch Neurol"},{"key":"9831_CR34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/bs.irn.2017.01.009","volume":"132","author":"C Koros","year":"2017","unstructured":"Koros C, Simitsi A, Stefanis L (2017) Genetics of Parkinson's disease: genotype-phenotype correlations. Int Rev Neurobiol 132:197\u2013231","journal-title":"Int Rev Neurobiol"},{"key":"9831_CR35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF03033571","volume":"11","author":"RM Kostrzewa","year":"2007","unstructured":"Kostrzewa RM (2007) The blood-brain barrier for cathecolamines \u2013 revisited. Neurotox Res 11:261\u2013271","journal-title":"Neurotox Res"},{"key":"9831_CR36","doi-asserted-by":"crossref","first-page":"33738","DOI":"10.1038\/srep33738","volume":"6","author":"N Kustrimovic","year":"2016","unstructured":"Kustrimovic N, Rasini E, Legnaro M, Bombelli R, Aleksic I, Blandini F, Comi C, Mauri M, Minafra B, Riboldazzi G, Sanchez-Guajardo V, Marino F, Cosentino M (2016) Dopaminergic receptors on CD4+ T naive and memory lymphocytes correlate with motor impairment in patients with Parkinson's disease. Sci Rep 6:33738","journal-title":"Sci Rep"},{"key":"9831_CR37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12974-018-1248-8","volume":"15","author":"N Kustrimovic","year":"2018","unstructured":"Kustrimovic N, Comi C, Magistrelli L, Rasini E, Legnaro M, Bombelli R, Aleksic I, Blandini F, Minafra B, Riboldazzi G, Sturchio A, Mauri M, Bono G, Marino F, Cosentino M (2018) Parkinson's disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1\/Th2\/T17 and Treg in drug-na\u00efve and drug-treated patients. J Neuroinflammation 15:205","journal-title":"J Neuroinflammation"},{"key":"9831_CR38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.pneurobio.2010.01.011","volume":"91","author":"G Laureys","year":"2010","unstructured":"Laureys G, Clinckers R, Gerlo S, Spooren A, Wilczak N, Kooijman R, Smolders I, Michotte Y, de Keyser J (2010) Astrocytic \u03b2-2 adrenergic receptors: from physiology to pathology. Prog Neurobiol 91:189\u2013199","journal-title":"Prog Neurobiol"},{"key":"9831_CR39","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.5213\/inj.1836216.108","volume":"22","author":"W Lee","year":"2018","unstructured":"Lee W, Koh S, Hwang S, Kim SH (2018) Presynaptic dysfunction by familial factors in Parkinson disease. Int Neurourol J 22:S115\u2013S121","journal-title":"Int Neurourol J"},{"key":"9831_CR40","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1124\/jpet.111.179416","volume":"337","author":"D Lindenbach","year":"2011","unstructured":"Lindenbach D, Ostock CY, Eskow Jaunarajs KL, Dupre KB, Barnum CJ, Bhide N, Bishop C (2011) Behavioural and cellular modulation of L-DOPA-induced dyskinesia by \u03b2-adrenoceptor receptor blockade in the 6-OHDA lesioned rat. J Pharmacol Exp Ther 337:755\u2013765","journal-title":"J Pharmacol Exp Ther"},{"key":"9831_CR41","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.12659\/MSM.906184","volume":"24","author":"Y Liu","year":"2018","unstructured":"Liu Y, Rui XX, Shi H, Qiu YH, Peng YP (2018) Norepinephrine inhibits Th17 cells via beta2-adrenergic receptor (beta2-AR) signaling in a mouse model of rheumatoid arthritis. Med Sci Monit 24:1196\u20131204","journal-title":"Med Sci Monit"},{"key":"9831_CR42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1196\/annals.1351.017","volume":"1069","author":"GJ Maestroni","year":"2006","unstructured":"Maestroni GJ (2006) Sympathetic nervous system influence on the innate immune response. Ann N Y Acad Sci 1069:195\u2013207","journal-title":"Ann N Y Acad Sci"},{"key":"9831_CR43","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0165-5728(01)00322-8","volume":"117","author":"K Makhlouf","year":"2001","unstructured":"Makhlouf K, Comabella M, Imitola J, Weiner HL, Khoury SJ (2001) Oral salbutamol decreases IL-12 in patients with secondary progressive multiple sclerosis. J Neuroimmunol 117:156\u2013165","journal-title":"J Neuroimmunol"},{"key":"9831_CR44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00726-011-1186-6","volume":"45","author":"F Marino","year":"2013","unstructured":"Marino F, Cosentino M (2013) Adrenergic modulation of immune cells: an update. Amino Acids 45:55\u201371","journal-title":"Amino Acids"},{"key":"9831_CR45","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.4103\/1673-5374.235013","volume":"13","author":"F Miraglia","year":"2018","unstructured":"Miraglia F, Ricci A, Rota L, Colla E (2018) Subcellular localization of alpha-synuclein aggregates and their interaction with membranes. Neural Regen Res 13:1136\u20131144","journal-title":"Neural Regen Res"},{"key":"9831_CR46","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1126\/science.aaf3934","volume":"357","author":"S Mittal","year":"2017","unstructured":"Mittal S, B\u00f8rnevik K, Soon Im D, Flierl A, Xianjun D, Locascio JJ et al (2017) \u03b22-Adrenoreceptor is a regulator of the synuclein gene driving risk of Parkinson\u2019s disease. Science 357:891\u2013898","journal-title":"Science"},{"key":"9831_CR47","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/ana.25341","volume":"84","author":"SS Nielsen","year":"2018","unstructured":"Nielsen SS, Gross A, Camacho-Soto A, Willis AW, Racette BA (2018) \u03b22-adrenoreceptor medications and risk of Parkinson disease. Ann Neurol 84:683\u2013693. \nhttps:\/\/doi.org\/10.1002\/ana.25341","journal-title":"Ann Neurol"},{"key":"9831_CR48","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/jlb.55.3.313","volume":"55","author":"N Paul-Eug\u00e8ne","year":"1994","unstructured":"Paul-Eug\u00e8ne N, Kolb JP, Damais C, Abadie A, Mencia-Huerta JM, Braquet P, Bousquet J, Dugas B (1994) Beta-2 adrenoceptors agonists regulate the IL-4-induced phenotypical changes and IgE-dependent functions in normal human monocytes. J Leukoc Biol 55:313\u2013320","journal-title":"J Leukoc Biol"},{"key":"9831_CR49","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0006-8993(85)90977-1","volume":"358","author":"A Pazos","year":"1985","unstructured":"Pazos A, Probst A, Palacios JM (1985) \u0392-adrenoceptor subtypes in the human brain: autoradiographic localization. Brain Res 358:201\u2013206","journal-title":"Brain Res"},{"key":"9831_CR50","doi-asserted-by":"crossref","first-page":"103780","DOI":"10.1155\/2014\/103780","volume":"2014","author":"L Peterson","year":"2014","unstructured":"Peterson L, Ismond KP, Chapman E, Flood P (2014) Potential benefits of therapeutic use of \u03b22-adrenergic receptor agonists in neuroprotection and Parkinson\u2019s disease. Journal of immunology research. J Immunol Res 2014:103780","journal-title":"J Immunol Res"},{"key":"9831_CR51","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/jnnp.52.2.201","volume":"52","author":"Pillon","year":"1989","unstructured":"Pillon, Dubois B, Cusimano G, Bonnet AM, Lhermitte F, Agid Y (1989) Does cognitive impairment in Parkinson\u2019s disease result from non-dopamingergic lesions? J Neurol Neurosurg Psychiatry 52:201\u2013206","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9831_CR52","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.4049\/jimmunol.1002449","volume":"186","author":"L Qian","year":"2011","unstructured":"Qian L, Wu HM, Chen AH, Zhang D, Ali SF, Peterson L et al (2011) \u03b22-adrenergic receptor activation prevents rodent dopaminergic neurotoxicity by inhibiting microglia via a novel signaling pathway. J Immunol 186:4443\u20134454","journal-title":"J Immunol"},{"key":"9831_CR53","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1073\/pnas.81.5.1585","volume":"81","author":"TC Rainbow","year":"1984","unstructured":"Rainbow TC, Parsons B, Wolfe BB (1984) Quantitative autoradiography of \u03b21-and \u03b22-adrenergic receptors in rat brain. Proc Natl Acad Sci U S A 81:1585\u20131589","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9831_CR54","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1440-1681.1988.tb01007.x","volume":"15","author":"D Ratge","year":"1988","unstructured":"Ratge D, Wiedemann A, Kohse KP, Wisser H (1988) Alterations of beta-adrenoceptors on human leukocyte subsets induced by dynamic exercise: effect of prednisone. Clin Exp Pharmacol Physiol 15:43\u201353","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"9831_CR55","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1001\/archneur.64.7.990","volume":"64","author":"B Ritz","year":"2007","unstructured":"Ritz B, Ascherio A, Checkoway H, Marder KS, Nelson LM, Rocca WA, Ross GW, Strickland D, van den Eeden SK, Gorell J (2007) Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol 64:990\u2013997","journal-title":"Arch Neurol"},{"key":"9831_CR56","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbi.2011.08.001","volume":"26","author":"VM Sanders","year":"2012","unstructured":"Sanders VM (2012) The beta2-adrenergic receptor on T and B lymphocytes: do we understand it yet? Brain, Behaviour and Immunity 26:195\u2013200","journal-title":"Brain, Behaviour and Immunity"},{"key":"9831_CR57","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fphar.2015.00171","volume":"6","author":"A Scanzano","year":"2015","unstructured":"Scanzano A, Cosentino M (2015) Adrenergic regulation of innate immunity: a review. Front Pharmacol 6:171. \nhttps:\/\/doi.org\/10.3389\/fphar.2015.00171","journal-title":"Front Pharmacol"},{"key":"9831_CR58","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00011-014-0791-8","volume":"64","author":"A Scanzano","year":"2015","unstructured":"Scanzano A, Schembri L, Rasini E, Luini A, Dellatorre J, Legnaro M et al (2015) Adrenergic modulation of migration, Cd11b and CD18 expression, ROS and interleukin-8 production by human polymorphonuclear leukocytes. Inflamm Res 64:127\u2013135","journal-title":"Inflamm Res"},{"key":"9831_CR59","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0006-8993(83)90993-9","volume":"275","author":"B Scatton","year":"1983","unstructured":"Scatton B, Javoy-Agid F, Rouquier L, Dubois B, Agid Y (1983) Reduction od cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson disease. Brain Res 275:321\u2013328","journal-title":"Brain Res"},{"key":"9831_CR60","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/WCO.0000000000000355","volume":"29","author":"M Stamelou","year":"2016","unstructured":"Stamelou M, Bhatia KP (2016) Atypical parkinsonism-new advances. Curr Opin Neurol 29:480\u2013485","journal-title":"Curr Opin Neurol"},{"key":"9831_CR61","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature22815","volume":"546","author":"D Sulzer","year":"2017","unstructured":"Sulzer D, Alcalay RN, Garretti F, Cote L, Kanter E, Agin-Liebes J, Liong C, McMurtrey C, Hildebrand WH, Mao X, Dawson VL, Dawson TM, Oseroff C, Pham J, Sidney J, Dillon MB, Carpenter C, Weiskopf D, Phillips E, Mallal S, Peters B, Frazier A, Lindestam Arlehamn CS, Sette A (2017) T cells from patients with Parkinson's disease recognize \u03b1-synuclein peptides. Nature 546:656\u2013661","journal-title":"Nature"},{"key":"9831_CR62","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/jnc.13691","volume":"139","author":"S Sveinbjornsdottir","year":"2016","unstructured":"Sveinbjornsdottir S (2016) The clinical symptoms of Parkinson's disease. J Neurochem 139:318\u2013324","journal-title":"J Neurochem"},{"key":"9831_CR63","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4049\/jimmunol.166.1.232","volume":"166","author":"MA Swanson","year":"2001","unstructured":"Swanson MA, Lee WT, Sanders VM (2001) IFN-gamma production by Th1 cells generated from naive CD4? T cells exposed to norepinephrine. J Immunol 166:232\u2013240","journal-title":"J Immunol"},{"key":"9831_CR64","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jneuroim.2004.03.001","volume":"151","author":"HK Takahashi","year":"2004","unstructured":"Takahashi HK, Iwagaki H, Mori S, Yoshino T, Tanaka N, Nishibori M (2004) Beta 2-adrenergic receptor agonist induces IL-18 production without IL-12 production. J Neuroimmunol 151:137\u2013147","journal-title":"J Neuroimmunol"},{"key":"9831_CR65","first-page":"1","volume":"5","author":"AW Tank","year":"2015","unstructured":"Tank AW, Wong DL (2015) Peripheral and central effects of circulating cathecolamines. Compr Physiol 5:1\u201315","journal-title":"Compr Physiol"},{"key":"9831_CR66","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neulet.2005.12.007","volume":"97","author":"YD Teng","year":"2006","unstructured":"Teng YD, Choi D, Huang R, Onario C, Frontera WR, Sydner EY et al (2006) Therapeutic effects of clenbuterol in a murine model of amyotrophic lateral sclerosis. Neurosci Lett 97:155\u2013158","journal-title":"Neurosci Lett"},{"key":"9831_CR67","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1016\/j.parkreldis.2015.09.032","volume":"22","author":"MA Thenganatt","year":"2016","unstructured":"Thenganatt MA, Jankovic J (2016) The relationship between essential tremor and Parkinson's disease. Parkinsonism Relat Disord 22:S162\u2013S165","journal-title":"Parkinsonism Relat Disord"},{"key":"9831_CR68","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/mds.10002","volume":"17","author":"EY Uc","year":"2002","unstructured":"Uc EY, Dienel GA, Cruz NF, Hark SI (2002) \u03b2-Adrenergics enhance brain extraction of levodopa. Mov Disord 17:54\u201359","journal-title":"Mov Disord"},{"key":"9831_CR69","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00002826-200307000-00011","volume":"26","author":"EY Uc","year":"2003","unstructured":"Uc EY, Lambert CP, Harik SI, Rodnitzky RL, Evans WJ (2003) Albuterol improves response to levodopa and increases skeletal muscle mass in patients with fluctuating Parkinson disease. Clin Neuropharmacol 26:207\u2013212","journal-title":"Clin Neuropharmacol"},{"key":"9831_CR70","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.celrep.2016.12.023","volume":"18","author":"KJ Vargas","year":"2017","unstructured":"Vargas KJ, Schrod N, Davis T, Fernandez-Busnadiego R, Taguchi YV, Laugks U, Lucic V, Chandra SS (2017) Synucleins have multiple effects on presynaptic architecture. Cell Rep 18:161\u2013173","journal-title":"Cell Rep"},{"key":"9831_CR71","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/syn.890080405","volume":"8","author":"C Waeber","year":"1991","unstructured":"Waeber C, Rigo M, Chinaglia G, Probst A, Palacios JM (1991) Beta-adrenergic receptor subtypes in the basal ganglia of patients with Huntington\u2019s chorea and Parkinson\u2019s disease. Synapse 8:270\u2013280","journal-title":"Synapse"},{"key":"9831_CR72","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/imm.12871","volume":"154","author":"L Xu","year":"2018","unstructured":"Xu L, Ding W, Stohl LL, Zhou XK, Azizi S, Chuang E, Lam J, Wagner JA, Granstein RD (2018) Regulation of T helper cell responses during antigen presentation by norepinephrine-exposed endothelial cells. Immunology 154:104\u2013121","journal-title":"Immunology"},{"issue":"9","key":"9831_CR73","volume":"12","author":"H Zhu","year":"2017","unstructured":"Zhu H, Lemos H, Bhatt B, Islam BN, Singh A, Gurav A, Huang L, Browning DD, Mellor A, Fulzele S, Singh N (2017) Carbidopa, a drug in use for management of Parkinson disease inhibits T cell activation and autoimmunity. PLoS One 12(9):e0183484","journal-title":"PLoS One"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-018-09831-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11481-018-09831-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-018-09831-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T16:08:02Z","timestamp":1586189282000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11481-018-09831-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,7]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["9831"],"URL":"https:\/\/doi.org\/10.1007\/s11481-018-09831-0","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,7]]},"assertion":[{"value":"26 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}